March 05, 2015 12:19 PM ET

Pharmaceuticals

Company Overview of Thrombolytic Science International, LLC

Company Overview

Thrombolytic Science International, LLC engages in the development of a thrombolytic product. It provides M5, a thrombolytic drug that is used for percutaneous coronary intervention and ischemic stroke. The company was incorporated in 2004 and is based in Cambridge, Massachusetts.

763D Concord Avenue

Cambridge, MA 02138

United States

Founded in 2004

Phone:

617-661-1103

Fax:

617-247-2501

Key Executives for Thrombolytic Science International, LLC

Co-Founder, Chief Executive Officer and President
Co-Founder and Scientific Director
Co-Founder
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Molecular Logix, Inc. United States
Bioplus Pharmaceuticals Inc. United States
AppGenoma United States
Visionary Therapeutics Corporation United States
Viroxis Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Thrombolytic Science International, LLC, please visit www.tsillc.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.